The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_001754.4(RUNX1):c.861C>A (p.Tyr287Ter)

CA248619

14467 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: fed802a7-8c1d-4396-89f1-65546e996764
Approved on: 2019-07-29
Published on: 2019-08-02

HGVS expressions

NM_001754.4:c.861C>A
NM_001754.4(RUNX1):c.861C>A (p.Tyr287Ter)
NC_000021.9:g.34799407G>T
CM000683.2:g.34799407G>T
NC_000021.8:g.36171704G>T
CM000683.1:g.36171704G>T
NC_000021.7:g.35093574G>T
NG_011402.2:g.1190305C>A
ENST00000675419.1:c.861C>A
ENST00000300305.7:c.861C>A
ENST00000344691.8:c.780C>A
ENST00000399240.5:c.588C>A
ENST00000437180.5:c.861C>A
ENST00000482318.5:c.*451C>A
NM_001001890.2:c.780C>A
NM_001001890.3:c.780C>A
NM_001754.5:c.861C>A
More

Pathogenic

Met criteria codes 4
PM2 PVS1 PS4_Supporting PP1_Strong
Not Met criteria codes 22
BS1 BS4 BS3 BS2 BP5 BP7 BP4 BP3 BP1 BP2 BA1 PM6 PS1 PS2 PS3 PM1 PM3 PM5 PM4 PP2 PP3 PP4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
The NM_001754.4:c.861C>A (p.Tyr287Ter) variant is a nonsense variant that is predicted to introduce a premature stop codon and expected to result in nonsense-mediated mRNA decay (PVS1). This variant was found to co-segregate with disease in multiple affected family members, with seven meioses observed in one family (PP1_Strong; PMID: 11830488). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2). The variant has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_ Supporting; PMID: 11830488). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PVS1, PP1_Strong, PM2, PS4_Supporting.
Met criteria codes
PM2
The variant is absent from all population databases.
PVS1
Nonsense variant before the c.916 cutoff that predict to undergo NMD
PS4_Supporting
One family with FPD/AML.

PP1_Strong
At least 7 meioses in the family with FPD/AML.

Not Met criteria codes
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.